Stocks · Health care · Services-Medical Laboratories

Guardant Health, Inc.

GH Clue Score49
United States Fiscal year ends December CIK 0001576280 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Helmy Eltoukhy
3 May 2024
Co-Chief Executive Officer
Exercised, kept
200,000
$4.18
$836.00K
AmirAli Talasaz
2 May 2024
Co-Chief Executive Officer
Exercised, kept
283,830
$4.18
$1.19M
Darya Chudova
16 Jan 2024
Chief Technology Officer
Exercised, kept
6,626
$8.80
$58.31K
Darya Chudova
15 Nov 2023
Chief Technology Officer
Exercised, kept
4,000
$8.80
$35.20K
Darya Chudova
28 Sep 2023
Chief Technology Officer
Exercised, kept
4,500
$8.80
$39.60K
Helmy Eltoukhy
13 Aug 2021
Co-Chief Executive Officer
Exercised, kept
23,923
$4.18
$100.00K
AmirAli Talasaz
13 Aug 2021
Co-Chief Executive Officer
Exercised, kept
23,923
$4.18
$100.00K
Showing 250 of 1,030 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 811
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 76
Sales straight out of an exercise 468
Sales at will 442
Transactions with no price 1
Shares from compensation/vesting 64,511,994
Sales filed before the plan box existed 385
History held since 11 Oct 2018